PubMed

Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.

Li PK, Chow KM, Wong TY, Leung CB, Szeto CC.

Ann Intern Med. 2003 Jul 15;139(2):105-12.PMID: 12859160 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.

Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G.

Lancet. 1998 Oct 17;352(9136):1252-6.PMID: 9788454 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Preventing worsening kidney function in patients receiving peritoneal dialysis.

[No authors listed]

Ann Intern Med. 2003 Jul 15;139(2):I32. No abstract available. PMID: 12859177 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

[No authors listed]

Lancet. 1997 Jun 28;349(9069):1857-63.PMID: 9217756 [PubMed - indexed for MEDLINE]Related articles

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group.

JAMA. 2002 Nov 20;288(19):2421-31. Erratum in: JAMA. 2006 Jun 21;295(23):2726. PMID: 12435255 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group.

JAMA. 2001 Jun 6;285(21):2719-28.PMID: 11386927 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of decline of residual renal function in new peritoneal dialysis patients.

Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P.

Perit Dial Int. 2003 May-Jun;23(3):276-83.PMID: 12938830 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators.

Lancet. 2008 Aug 16;372(9638):547-53.PMID: 18707986 [PubMed - indexed for MEDLINE]Related articles

A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.

Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.

Clin Nephrol. 2001 May;55(5):375-83.PMID: 11393383 [PubMed - indexed for MEDLINE]Related articles

In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia.

Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G.

J Am Soc Nephrol. 1999 May;10(5):997-1006.PMID: 10232685 [PubMed - indexed for MEDLINE]Related articlesFree article

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G.

Lancet. 1999 Jul 31;354(9176):359-64.PMID: 10437863 [PubMed - indexed for MEDLINE]Related articles

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.PMID: 10845831 [PubMed - indexed for MEDLINE]Related articles

Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.

Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, Li PK.

Nephrol Dial Transplant. 2005 Feb;20(2):396-403. Epub 2004 Jun 8.PMID: 15187196 [PubMed - indexed for MEDLINE]Related articlesFree article

Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.

Ruggenenti P, Perna A, Remuzzi G; GISEN Group Investigators.

Kidney Int. 2003 Jun;63(6):2254-61.PMID: 12753315 [PubMed - indexed for MEDLINE]Related articles

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.

Arch Intern Med. 2005 Apr 25;165(8):936-46.PMID: 15851647 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.

Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL.

Arch Intern Med. 2005 Apr 25;165(8):947-53.PMID: 15851648 [PubMed - indexed for MEDLINE]Related articlesFree article

Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it.

Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG.

Perit Dial Int. 2000 Jul-Aug;20(4):429-38.PMID: 11007375 [PubMed - indexed for MEDLINE]Related articlesFree article

Strict blood-pressure control and progression of renal failure in children.

ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.

N Engl J Med. 2009 Oct 22;361(17):1639-50.PMID: 19846849 [PubMed - indexed for MEDLINE]Related articles

Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.

McCarthy JT, Jenson BM, Squillace DP, Williams AW.

Am J Kidney Dis. 1997 Apr;29(4):576-83.PMID: 9100048 [PubMed - indexed for MEDLINE]Related articles

ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.

Ruggenenti P, Perna A, Remuzzi G; Gruppo Italiano di Studi Epidemiologici in Nefrologia.

J Am Soc Nephrol. 2001 Dec;12(12):2832-7.PMID: 11729254 [PubMed - indexed for MEDLINE]Related articlesFree article